Fresenius Kabi
Marco Brusasca is a seasoned professional in the pharmaceutical industry, currently serving as Senior Manager of Scientific Project Management at Fresenius Kabi since December 2022, where responsibilities include coordinating technical activities for key intermediates and APIs, as well as supplier selection and validation. Previously, Marco held various roles at Farmabios from November 2011 to November 2022, including Project Manager NPD/CS and Senior Research Scientist/Project Leader, focusing on API development and project management across international collaborations. Marco has also contributed to academia as a Guest Lecturer at the Master II livello PRO_API Università di Perugia and has a solid educational background with multiple degrees, including an MPhil in Design and Development of APIs and an International Part-Time MBA from MIP Politecnico di Milano.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.